Add to ORKGbetween gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcome
Purpose: To evaluate the patency of sirolimus-eluting stents (SES) compared to bare-metal stents (BM...
Atherosclerotic renal artery stenosis is common and is associated with hypertension and chronic kidn...
Background. Atherosclerotic renal artery stenosis (ARAS) can lead to end-stage renal failure (ESRF)....
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic r...
Atherosclerotic renal artery stenosis is prevalent patients without ARAS (56.3%) against those with ...
Gadolinium chelates have been recently proposed and preliminarily tested as contrast agents for diag...
Item does not contain fulltextA reduction in the diameter of the renal arteries can lead to hyperten...
Renal artery stenosis (RAS) is increasingly diagnosed in the expanding elderly population and has be...
Item does not contain fulltextPURPOSE OF REVIEW: Randomized trials have failed to show clinical bene...
It is unclear whether revascularization of renal artery stenosis (RAS) by means of percutaneous rena...
It is unclear whether revascularization of renal artery stenosis (RAS) by means of percutaneous rena...
To determine the prevalence of renal artery stenosis (RAS) in patients who have undergone cineangioc...
Purpose: To evaluate the patency of sirolimus-eluting stents (SES) compared to bare-metal stents (BM...
Item does not contain fulltextBACKGROUND: Atherosclerotic renal artery stenosis (ARAS) is associated...
Atherosclerotic renal artery stenosis is known to be one of the most common causes of secondary hype...
Purpose: To evaluate the patency of sirolimus-eluting stents (SES) compared to bare-metal stents (BM...
Atherosclerotic renal artery stenosis is common and is associated with hypertension and chronic kidn...
Background. Atherosclerotic renal artery stenosis (ARAS) can lead to end-stage renal failure (ESRF)....
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic r...
Atherosclerotic renal artery stenosis is prevalent patients without ARAS (56.3%) against those with ...
Gadolinium chelates have been recently proposed and preliminarily tested as contrast agents for diag...
Item does not contain fulltextA reduction in the diameter of the renal arteries can lead to hyperten...
Renal artery stenosis (RAS) is increasingly diagnosed in the expanding elderly population and has be...
Item does not contain fulltextPURPOSE OF REVIEW: Randomized trials have failed to show clinical bene...
It is unclear whether revascularization of renal artery stenosis (RAS) by means of percutaneous rena...
It is unclear whether revascularization of renal artery stenosis (RAS) by means of percutaneous rena...
To determine the prevalence of renal artery stenosis (RAS) in patients who have undergone cineangioc...
Purpose: To evaluate the patency of sirolimus-eluting stents (SES) compared to bare-metal stents (BM...
Item does not contain fulltextBACKGROUND: Atherosclerotic renal artery stenosis (ARAS) is associated...
Atherosclerotic renal artery stenosis is known to be one of the most common causes of secondary hype...
Purpose: To evaluate the patency of sirolimus-eluting stents (SES) compared to bare-metal stents (BM...
Atherosclerotic renal artery stenosis is common and is associated with hypertension and chronic kidn...
Background. Atherosclerotic renal artery stenosis (ARAS) can lead to end-stage renal failure (ESRF)....